Home > Daniel R Ouellette, ERS 2018 – E-cigarettes and respiratory disease
Asthma, COPD

Daniel R Ouellette, ERS 2018 – E-cigarettes and respiratory disease

Published Online: September 21st 2018

Editorial board member Daniel R Ouellette (Wayne State University School of Medicine, Detroit, MI, US) considers what is known to-date about the impact of e-cigarettes or vaping versus traditional tobacco products on respiratory disease.


1. What is the overall effect on respiratory disease of switching from smoking tobacco to vaping? (0:12)
2. What is the effect of e-cigarettes on exacerbations of asthma and COPD? (0:48)
3. What components of e-cigarettes may contribute to a decrease in respiratory health? (1:31)
4. How does the use of e-cigarette use among young people affect their likelihood of later using traditional tobacco products? (2:01)

5. What studies of vaping would you like to see performed in the future? (2:41)

Speaker disclosure: Daniel R Ouellette has nothing to disclose in relation to this video interview.

Filmed at the European Respiratory Society (ERS) International Congress 2018, Paris, France, September 2018.

Related Videos In COPD
  • Journal articles and more to your inbox

    Get the latest clinical insights from touchRESPIRATORY

    Sign me up!
    Copied to clipboard!
    accredited arrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greyarrow-right-orangearrow-right-whitearrow-right-blueavatarcalendarchevron-down crosscrossdownloademailexclaimationfeedbackfiltergraph-arrowlinkmenumore_dots padlock person play-colourAsset 1podcastprinter search share social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-whiteticktimetranscriptup-arrow